Use of Continuous Glucose Monitoring and Glucagon-Like Peptide 1 Receptor Agonist Therapy to Achieve Individualized Treatment Goals in Insulin-Treated People with Type 2 Diabetes: A Case Series and Expert Opinion

Authors

N. Ehrhardt
V. Aroda
R. Galindo
A. Peters
Jay H. Shubrook, Touro University CaliforniaFollow

Roles

Author

Document Type

Article

Publication Date

1-1-2024

Publication Title

Clinical Diabetes

DOI

10.2337/cd23-0047

Recommended Citation

Ehrhardt, N., Aroda, V., Galindo, R., Peters, A., & Shubrook, J. H. (2024). Use of Continuous Glucose Monitoring and Glucagon-Like Peptide 1 Receptor Agonist Therapy to Achieve Individualized Treatment Goals in Insulin-Treated People with Type 2 Diabetes: A Case Series and Expert Opinion. Clinical Diabetes, 42 (2), 341–350. https://doi.org/10.2337/cd23-0047